Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma

Mansfield AS1, Peikert T2, Smadbeck JB3, Udell JBM4, Garcia-Rivera E5, Elsbernd L6, Erskine CL6, Van Keulen VP6, Kosari F3, Murphy SJ3, Ren H7, Serla VV3, Schaefer Klein JL3, Karagouga G3, Harris FR3, Sosa C3, Johnson SH3, Nevala W6, Markovic SN1, Bungum AO2, Edell ES2, Dong H8, Cheville JC7, Aubry MC7, Jen J9, Vasmatzis G10 1 Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. 2 Division of Pulmonary Medicine and Critical Care, Mayo Clinic, Rochester, Minnesota. 3 Center for Individualized Medicine, Biomarker Discovery Group, Mayo Clinic, Rochester, Minnesota. 4 Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota. 5 nference, Cambridge, Massachusetts. 6 Department of Immunology, Mayo Clinic, Rochester, Minnesota. 7 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. 8 Department of Immunology, Mayo Clinic, Rochester, Minnesota; Department of Urology, Mayo Clinic, Rochester, Minnesota. 9 Medical Genome Facility, Mayo Clinic, Rochester, Minnesota. 10 Center for Individualized Medicine, Biomarker Discovery Group, Mayo Clinic, Rochester, Minnesota. Electronic address: vasmatzis.george@mayo.edu